Prime Emblem Spotlights Fast, Premium Custom Patch Production for US Brands and Teams

TAVARES, FL, UNITED STATES, February 12, 2026 /EINPresswire.com/ -- When a uniform refresh is due, a merch drop is on ...

FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Johnson & Johnson (NYSE: JNJ) today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPRO™ (amivantamab and ...